Inhibitory Effect of Fluvastatin on Lysophosphatidylcholine-Induced Nonselective Cation Current in Guinea Pig Ventricular Myocytes
Authors:
- Isao MatsuokaIMIsao Matsuoka
- Yuichi SuzukiYSYuichi Suzuki
- Yasuhide WatanabeYWYasuhide Watanabe
- Toshiyuki IshibashiTIToshiyuki Ishibashi
- Keiko YokoyamaKYKeiko Yokoyama
- Yukio MaruyamaYMYukio Maruyama
- Junko KimuraJKJunko Kimura
- 1 September 2002
- journal article
- Published by Elsevier in Molecular Pharmacology
- Vol. 62 (3) , 602-607
Abstract
GH3 cells show spontaneous activity characterized by bursts of action potentials and oscillations in [Ca2+]i. This activity is modulated by the activation of exogenously expressed opioid receptors. In GH3 cells expressing only μ receptors (GH3MOR cells), the μ receptor-specific ligand [d-Ala2,N-Me-Phe4,Gly5-ol]-enkephalin (DAMGO) inhibited spontaneous Ca2+ signaling by the inhibition of voltage-gated Ca2+ channels, activation of inward-rectifying K+ channels, and inhibition of adenylyl cyclase. In contrast, in cells expressing both μ and δ receptors (GH3MORDOR cells), DAMGO had an excitatory effect on Ca2+ signaling that was mediated by phospholipase C and release of Ca2+ from intracellular stores. The excitatory effect of DAMGO was also inhibited by pretreatment with pertussis toxin. Despite the excitatory effect on Ca2+ signaling, DAMGO inhibited Ca2+ channels and activated inward-rectifying K+ channels in GH3MORDOR cells, although to a lesser extent than in GH3MOR cells. Long-term treatment with the δ receptor-specific ligand [d-Pen2,d-Pen5]-enkephalin reduced the excitatory effect of DAMGO in the majority of GH3MORDOR cells and restored the inhibitory response to DAMGO in some cells. The inhibitory effect of somatostatin on Ca2+ signaling was not different in GH3MORDOR versus GH3MOR cells. These results indicate that interaction between μ- and δ-opioid receptors causes a change in the functional response to μ ligands, possibly by the formation of a μ/δ heterodimer with distinct functional properties.Keywords
This publication has 29 references indexed in Scilit:
- Lysophosphatidylcholine as a Ligand for the Immunoregulatory Receptor G2AScience, 2001
- Sphingosylphosphocholine is a naturally occurring lipid mediator in blood plasma: a possible role in regulating cardiac function via sphingolipid receptorsBiochemical Journal, 2001
- Lysophospholipid ReceptorsAnnual Review of Pharmacology and Toxicology, 2001
- New insights into the pharmacodynamic and pharmacokinetic properties of statinsPharmacology & Therapeutics, 1999
- Post-transcriptional Regulation of Endothelial Nitric Oxide Synthase mRNA Stability by Rho GTPaseJournal of Biological Chemistry, 1998
- Lysophosphatidylcholine: A Possible Modulator of Ischemic Injury in the Heart1998
- A Study on Dilazep: II. Dilazep Attenuates Lysophosphatidylcholine-Induced Mechanical and Metabolic Derangements in the Isolated, Working Rat HeartThe Japanese Journal of Pharmacology, 1995
- Prenyl proteins in eukaryotic cells: a new type of membrane anchorTrends in Biochemical Sciences, 1990
- Regulation of the mevalonate pathwayNature, 1990
- Calcium tolerant ventricular myocytes prepared by preincubation in a ?KB medium?Pflügers Archiv - European Journal of Physiology, 1982